Video
Eating more fruit may decrease the risk of suffering from abdominal aortic aneurysm, according to new research in the American Heart Association journal Circulation. In a Swedish study, people who reported eating more than two servings of fruit daily had a lower risk of abdominal aortic aneurysm than those who ate the least amount of fruit.
On 26 August 2013 Volcano said it has signed an agreement to acquire the Pioneer Plus diagnostic ultrasound transducer and percutaneous catheter from Medtronic. The transaction is structured as an asset purchase and is expected to close by the end of August, subject to customary closing conditions.
Intact Vascular, Inc. (Wayne, PA) announced the completion of enrollment in the multicenter TOBA (Tack Optimized Balloon Angioplasty) study, which is being conducted to gather confirmatory data on the use of the company’s Tack-It endovascular system in the superficial femoral and popliteal arteries.
Cook Medical has completed patient enrolment in a study evaluating the retrograde tibiopedal approach. The new access technique could be used in treating peripheral arterial disease, including for patients with critical limb ischaemia.
On 15 August, Medtronic announced the submission of its first pre-market approval (PMA) module to the FDA for the In.pact Admiral drug-eluting balloon. Designed to treat atherosclerotic lesions in the superficial femoral artery, the novel angioplasty device remains investigational in the USA.
At the Society for Vascular Surgery (SVS) Vascular Annual Meeting (30 May–1 June 2013, San Francisco, USA), Tina M Morrison (Center for Devices and Radiological Health, Food and Drug Administration, Silver Spring, USA), gave a presentation on the eligibility for endovascular repair of short neck abdominal aortic aneurysms from the CHAP project.
Results of the INSTEAD-XL, published in Circulation: Cardiovascular Interventions, show that thoracic endovascular aortic repair of uncomplicated type B dissections in addition to medical therapy is associated with improved five-year aorta-specific survival and delayed disease progression. The data from the study were published online on 6 August 2013.
Harvard Stem Cell Institute (HSCI) scientists have successfully grown the cells that line the blood vessels—called vascular endothelial cells—from human induced pluripotent stem cells (iPSCs), revealing new details about how these cells function.
Cook Medical is shipping its Zilver PTX drug-eluting peripheral stent to medical centres in the USA, Japan, Europe and other major markets again. The shipments follow a brief period of unavailability due to a voluntary recall by Cook related to an issue with the stent’s delivery catheter that has been resolved.
Peter Goverde who presented the Belgian registry results at EuroPCR 2013 in Paris, France (21–24 May), said that stenting of the superficial femoral artery with the biodegradable Remedy stent was safe and feasible.
Covidien (Mansfield, MA) has commenced enrollment in the ILLUMENATE Pivotal and ILLUMENATE PK (Pharmacokinetics) trials, which are components of the global ILLUMENATE clinical trial program. This program is a series of studies on the safety and effectiveness of Covidien’s Stellarex drug-coated angioplasty balloon for the treatment of patients with peripheral arterial disease (PAD).
One-year results of the VIASTAR trial published online in the Journal of the American College of Cardiology suggest that a heparin-bonded covered stent may be superior to bare metal stents in the treatment of long femoropopliteal artery disease.
Video
Medtronic, Inc. (Minneapolis, MN) announced that the US Food and Drug Administration (FDA) has approved the company’s Complete SE self-expanding vascular stent for use in the superficial femoral artery (SFA) and proximal popliteal artery (PPA).
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos